Patel Chem Specialities Posts Strong Growth in FY26

Revenue grew by 31.8% to Rs 139.08 crore; Profit After Tax rose 18.9% to Rs 12.55 crore.

Reader Takeaway: Robust pharmaceutical excipient demand drives top-line growth, though investors must track capacity utilization at the expanded Talod facility.

What just happened

Patel Chem Specialities reported its financial performance for FY 2025-26, highlighting a period of significant scaling. The company successfully grew its top-line revenue to Rs 139.08 crore, compared to Rs 105.55 crore in the previous fiscal year. Profitability followed suit, with net profit climbing to Rs 12.55 crore. The company also successfully completed its IPO on the BSE SME platform in August 2025, raising Rs 58.80 crore to fund its expansion plans.

Business Performance and Capacity Expansion

The company has made major strides in infrastructure. The expansion of its Talod plant is now complete, boosting annual production capacity from 720 MT to 4,500 MT, with trial batches already underway. Furthermore, the company has broken ground on a new greenfield facility in Indrad, Mehsana, which is slated to provide an additional 6,012 MT of capacity for high-demand pharmaceutical excipients like Sodium Starch Glycolate (SSG) and Croscarmellose Sodium (CCS).

Risks to watch

Growth is contingent on operational execution. Management faces risks related to the effective ramp-up of the Talod unit and the timely completion of the Indrad facility. Like many chemical manufacturers, Patel Chem is also exposed to volatile raw material costs, currency fluctuation risks, and a highly competitive pharmaceutical excipient market.

Context metrics

• Basic EPS: Rs 6.63 in FY26 (up from Rs 6.10 in FY25)
• EBITDA Margin: The company reported EBITDA of Rs 18.89 crore, reflecting a 19.6% year-on-year growth.
• Audit Status: Unmodified opinion provided by Parikh Shah & Associates.

What to track next

The primary focus for shareholders should be the revenue contribution from the newly expanded Talod capacity and construction milestones at the Indrad site in the coming quarters.